Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES: HBV Vaccine Recommended for All Unvaccinated at Risk HCP


Healio (01.03.2014) Aids Weekly Plus

Healio reported that CDC recommended all unvaccinated or incompletely vaccinated healthcare personnel (HCP) who risk exposure to blood or body fluids receive hepatitis B virus (HBV) vaccination. Vaccinated HCP should have serologic testing one to two months after the final dose. HBV antibody levels of 10 milli-International Units per milliliter (mIU/mL) or more indicated immunity; HCPs with antibody levels lower than 10mIU/mL should have an additional dose of HBV vaccine and another serologic test in one to two months. Although the number of acute HBV infections has declined in the United States, HCPs still risked exposure from patients with chronic HBV. CDC recommended testing newly hired and graduating HCPs and administering additional doses of HBV vaccine, as necessary, to protect them from exposure. Initial post-exposure management included “washing wounds and skin sites exposed with soap and water”; testing known HBV sources; referring the patient for appropriate management; and reporting the HBV infection to state or local authorities. When the exposure source was unknown, the exposed person should receive treatment as if the source were HBV-infected. An exposed HCP who was unvaccinated, incompletely vaccinated, or had no documented vaccination should have one dose of HBV immune globulin and a vaccine dose as soon as possible after exposure to a confirmed source. The HCP should complete the vaccine series and have antibody testing. Even if the exposure source did not have HBV, the HCP should have the vaccine series and antibody testing. HCP with antibody levels of 10 mIU/mL or more at the time of testing did not require post-exposure HBV management. Those with lower levels should have one dose of HBV immune globulin and vaccination. The full article, “CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management” was published online in the Morbidity and Mortality Weekly Report at


Copyright © 2014 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in January 6, 2014. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.